Atea Pharmaceuticals's total assets for Q1 2025 were $439.96M, a decrease of -5.32% from the previous quarter. AVIR total liabilities were $28.88M for the fiscal quarter, a 11.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.